|
Video: What is a Stock Split?
|
|
Eiger BioPharmaceuticals is a commercial-stage biopharmaceutical company. Co.'s portfolio includes a late-stage clinical development pipeline with five clinical product candidates and one U.S. Food and Drug Administration (FDA)-approved product. Co.'s clinical product candidates include: Lonafarnib for Hepatitis Delta Virus (HDV), Peginterferon Lambda for HDV, Combination Therapy for HDV; Peginterferon Lambda (lambda) for COVID-19, Avexitide in Congenital Hyperinsulinism, and Avexitide in Post-Bariatric Hypoglycemia. Co. has received FDA approval for Zokinvy to reduce the risk of mortality in Progeria and to treat processing-deficient Progeroid Laminopathies. According to our EIGR split history records, EIGR has had 2 splits. | |
|
EIGR (EIGR) has 2 splits in our EIGR split history database. The first split for EIGR took place on March 23, 2016. This was a 1 for 15 reverse split, meaning for each 15 shares of EIGR owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 66.6666666666667 share position following the split. EIGR's second split took place on January 08, 2024. This was a 1 for 30 reverse split, meaning for each 30 shares of EIGR owned pre-split, the shareholder now owned 1 share. For example, a 66.6666666666667 share position pre-split, became a 2.22222222222222 share position following the split.
When a company such as EIGR conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the EIGR split history from start to finish, an original position size of 1000 shares would have turned into 2.22222222222222 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into EIGR shares, starting with a $10,000 purchase of EIGR, presented on a split-history-adjusted basis factoring in the complete EIGR split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/22/2014 |
|
End date: |
04/10/2024 |
|
Start price/share: |
$5,589.00 |
|
End price/share: |
$1.73 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-99.97% |
|
Average Annual Total Return: |
-55.53% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$3.09 |
|
Years: |
9.98 |
|
|
|
Date |
Ratio |
03/23/2016 | 1 for 15 | 01/08/2024 | 1 for 30 |
|
|